Technology | February 25, 2015

ScottCare Showcases novi Patch Holter Monitor at ACC.15

Device allows quick identification of abnormal heart rhythms with minimal patient preparation time

ScottCare, novi, Holter monitor, EP lab, ACC 2015, remote monitoring

Image courtesy of ScottCare Corp.

February 25, 2015 — The ScottCare Corp. announced its new novi patch Holter monitor will be available in the United States for the first time at the 2015 Scientific Sessions of the American College of Cardiology in San Diego, Calif., March 14-16.

The novi is a small advanced patch Holter recorder for use by cardiology practices, hospitals and independent diagnostic testing facilities. The device allows clinicians to quickly and easily identify abnormal heart rhythms for their patients while minimizing the patient preparation time required by traditional Holter monitors. When attached to the sternum the novi begins recording immediately and automatically shuts off upon removal.

The device improves patient compliance due to its discreet appearance and ease of use. The unit is less than 2 inches in size, weighs just half an ounce, is water resistant and uses a rechargeable built-in battery. The novi records for up to 72 hours utilizing a single disposable patch electrode that minimizes motion artifact, resulting in improved electrocardiogram (ECG) quality and more accurate analysis.

The novi is integrated with ScottCare’s HolterCare software, allowing clinicians to easily record and report on patients’ ambulatory ECG- and cardiac-related symptoms. Current ScottCare customers who already own Chroma or RZ153+ Holter recorders will be able to quickly integrate the novi and its data into their monitoring workflow.

For more information: www.scottcare.com

Related Content

OTC ECG devices

OTC ECG devices can help detect abnormal heart rhythms in the general population, and this technology will continue to improve.

Feature | ECG | March 11, 2020
Apple created a stir when it...
Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 

Several wearable, less-obtrusive ECG monitors have been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 

Feature | ECG | February 19, 2020
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “...
The Bittium Faros uses a 4-in-1 ECG technology. It is a lightweight, waterproof and can be configured for different patient monitoring needs. Bittium Faros Holter monitoring.

The Bittium Faros uses a 4-in-1 ECG technology. It is a lightweight, waterproof and can be configured for different patient monitoring needs. 
 

News | ECG | January 22, 2020
January 22, 2020 – Bittium is exhibiting solutions for cardiology at...
Cardiologs
News | ECG | December 12, 2019
December 12, 2019 — Cardiologs, a global leader in artificial intelligence (AI)
FDA Clears AliveCor's KardiaMobile 6L as First Six-Lead Personal ECG Device
Technology | ECG | May 13, 2019
AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making KardiaMobile 6L...
One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

Feature | ECG | May 03, 2019 | Sanket Solanki
Technology has made its way into the healthcare sector and brought a drastic transformation.
Videos | ECG | March 05, 2019
This is a quick demo of the Schiller Cardiovit FT-1 electrocardiograph (ECG) system displayed at the ...
EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor
News | ECG | January 08, 2019
January 8, 2019 — A Mayo Clinic study finds that applying...
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer. 

Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the effe
HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...